About Jason

Jason Cole has 20 years of executive-level experience in the biotechnology industry with a track record of success at public and private biotechnology companies, advancing first-in-class therapies from discovery through approval. His most recent role was as Chief Executive Officer and Chair of the Board at SalioGen Therapeutics. He also served at Chief Strategy & Financial Officer, Chief Business Officer and Chief Operating and Legal Officer at bluebird bio. Previously, Jason served on the executive leadership teams of Zalicus and CombinatorRx. He holds a J.D. from Columbia University and an A.B. in Government from Dartmouth College.